Vivani Medical, Inc. (NASDAQ: VANI) announced the appointment of August Moretti to its board of directors, alongside the retirement of Dr. Dean Baker, according to a company press release.

Moretti will serve as chair of the Audit Committee and as a member of the Compensation Committee. He most recently served as Chief Financial Officer of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) from 2019 until his retirement in September 2023. Prior to that role, he served as CFO of Assertio Therapeutics from 2012 to 2018, and held CFO and General Counsel positions at Alexza Pharmaceuticals and Alavita, Inc. Earlier in his career, Moretti was a partner at Heller Ehrman, where he represented life science companies in mergers, acquisitions, and public financings. He currently serves on the board and chairs the Audit Committee of Cibus, Inc. Moretti holds a B.A. in Economics from Princeton University and a J.D. from Harvard Law School.

Dr. Baker's tenure on the board included roles as chair of the Audit Committee, chair of the Compensation Committee, and member of the Corporate Governance Committee. He provided guidance during the merger of Nano Precision Medical and Second Sight Medical Products. His career included senior leadership positions at Northrop Grumman, Advanced Bionics, and the Alfred E. Mann Institute at USC.

"On behalf of the entire board, I want to thank Dean for his dedicated service and invaluable contributions to Vivani," said Gregg Williams, Chairman of the Board.

Vivani is a clinical-stage biopharmaceutical company developing subdermal drug implants using its NanoPortal technology.